Literature DB >> 16142362

Impact of orotate phosphoribosyl transferase activity as a predictor of lymph node metastasis in gastric cancer.

Takumi Ochiai1, Michiharu Sugitani, Kazuhiko Nishimura, Hajime Noguchi, Tsuyoshi Okada, Masakazu Ouchi, Masaki Yamada, Masayuki Kitajima, Yuko Tsuruoka, Yuka Takahashi, Shunji Futagawa.   

Abstract

Orotate phosphoribosyl transferase (OPRT) is an essential nucleotide metabolic enzyme for cell proliferation and also a key enzyme for conversion of 5-FU to its active form in tumor tissue. The association between tumor OPRT activity and pathophysiological status, including lymph node metastasis [pN+], and the impact of OPRT for predicting pN+ were investigated in gastric cancer. The lymph node status of 73 resectable gastric cancer patients was analyzed preoperatively by computed tomography (CT), ultrasonography and magnetic resonance, and the OPRT activity of collected tumor tissue was measured. Then these data were compared with pathological observation of a surgical lymph node specimen. OPRT activity in the tumor tissue decreased as the depth of invasion increased. An OPRT test demonstrated superior sensitivity and comparable accuracy and sensitivity for predicting pN+, against current imaging diagnoses. Furthermore, the analysis of node negative patients by CT revealed that 80% of false negative patients were retrieved by this OPRT test. Thus, OPRT activity in tumor tissue was a powerful predictor of pN+ in resectable gastric cancer, and the preoperative OPRT test, when it becomes possible, would provide a basis for accurate evaluation of disease status, which is indispensable for the planning of personalized therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142362

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Levels and expressions of orotate phosphoribosyltransferase in gastric carcinoma and normal gastric mucosa tissues.

Authors:  Yoichi Sakurai; Shingo Kamoshida; Shinpei Furuta; Risaburo Sunagawa; Kazuki Inaba; Jun Isogaki; Yoshiyuki Komori; Ichiro Uyama; Yutaka Tsutsumi
Journal:  Gastric Cancer       Date:  2007-12-25       Impact factor: 7.370

2.  Expression of orotate phosphoribosyltransferase (OPRT) in hepatobiliary and pancreatic carcinoma.

Authors:  Yuichi Sanada; Kazuhiro Yoshida; Masahiro Ohara; Yasuhiro Tsutani
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

3.  Predictive value of orotate phosphoribosyltransferase in colorectal cancer patients receiving 5-FU-based chemotherapy.

Authors:  Shuji Komori; Shinji Osada; Hiroyuki Tomita; Kimitoshi Nishio; Iwao Kumazawa; Susumu Tachibana; Juji Tsuchiya; Kazuhiro Yoshida
Journal:  Mol Clin Oncol       Date:  2013-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.